Research
In this paper, we discuss the unique features of the market for anticancer drugs and assess trends in the launch prices for 58 anticancer drugs approved between 1995 and 2013 in the United States.
American Economic Association
December 13, 2016
Research
Dr. Peter Bach responds to industry leaders who argue that high prices are necessary for innovation.
Forbes: Cancer
October 23, 2016
News
Dr. Peter Bach discusses how copay assistance programs are actually causing drug prices to rise on Closing Bell.